Overview
- The Whole Health Oncology Institute's meta-analysis, published on April 15, 2025, is the largest-ever study of medical cannabis and cancer, analyzing over 10,000 studies using AI techniques.
- Findings show 75% of studies support medical cannabis for alleviating cancer-related symptoms like nausea, inflammation, and appetite loss, with evidence suggesting potential tumor-fighting properties.
- The study highlights cannabis's ability to induce cancer cell death and inhibit their spread, though larger clinical trials are needed to confirm its efficacy in humans.
- Researchers cite federal Schedule I classification as a major barrier to conducting large-scale human trials and urge the DEA to reclassify cannabis to facilitate further research.
- Experts remain divided, with some skeptical of cannabis's direct anticancer effects, emphasizing the need for comprehensive clinical validation despite promising preclinical and observational evidence.